Top 27 Dicerna Pharmaceuticals investors
The most complete profiles first. Showing 27 of 27.
Annie MitsakVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Brian HalakVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 61 more
Verified email available
Ken HaasVerified
Venture Capital, Advisor, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Peter KolchinskyVerified
Venture Capital, Angel/Individual, Investor · United States
SeedHealth CareEnterprise SoftwareInvestment ManagementBiotechnologyPortfolio: Moderna Therapeutics, ARS Pharmaceuticals, Novavax, Zipline Medical and 6 more
Verified email available
andrew sinclairVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
AnneVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Eckard WeberVerified
Venture Capital · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 53 more
Verified email available
James CavanaughVerified
Venture Capital · United States
Health CareWearablesGeneticsE-commercePortfolio: Apofore, Catalyst Biosciences, Avidia, Proteostasis Therapeutics and 52 more
Verified email available
Jim BlairVerified
Venture Capital · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 53 more
Verified email available
Matthew FoyVerified
Corporate Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Semprus BioSciences, Pulmocide, Syntaxin, CRISPR Therapeutics and 50 more
Verified email available
Oleg NodelmanVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Paulina HillVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Sarah MarriottVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Scott PlatshonVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Shelley ChuVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Tim HainesVerified
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Bali Muralidhar
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more
Contact details available
Brian Gallagher, Jr.
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more
Contact details available
Francesco Draetta
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
Jesse Treu
Venture Capital, Founder, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 55 more
Contact details available
Katie Kerfoot
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
Kurt von Emster
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedInvestment ManagementLife SciencePortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Michelle Doig
Venture Capital, Investor · Canada
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
Vin Miles
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Caroline Stout
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Contact details available
John Heard
Venture Capital, Private Equity Firm · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Sarah Shackelton
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Dicerna Pharmaceuticals investors are on Angel Roster?
Angel Roster lists 27 Dicerna Pharmaceuticals investors. 16 of them (59%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (26), Private Equity Firms (9) and Founder-Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Dicerna Pharmaceuticals investors invest in?
Among those that list a stage, the most common are Seed (7) and Series B (6).
Where are Dicerna Pharmaceuticals investors based?
Most are based in the United States (20), the United Kingdom (6) and Canada (1).
Which companies have Dicerna Pharmaceuticals investors backed?
The most-backed portfolio companies among them are Scorpion Therapeutics (20), Spruce Biosciences (16), Median Technologies (16), IFM Therapeutics (16) and Paratek Pharmaceuticals (16).
How do I contact Dicerna Pharmaceuticals investors?
Create a free Angel Roster account to search and filter all 27, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.